Antibody-drug conjugates in oncology: insights into Current challenges

被引：3
|
作者：
Al Meslamani, Ahmad Z. [1 ,2 ]
Bostanudin, Mohammad F. [1 ,2 ]
机构：
[1] Al Ain Univ, Coll Pharm, Abu Dhabi, U Arab Emirates
[2] Al Ain Univ, AAU Hlth & Biomed Res Ctr, Abu Dhabi, U Arab Emirates
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2023年 / 23卷 / 11期
关键词：
ADCs; Challenges; Resistance; Cancer therapy; toxicity; heterogeneity;
D O I：
10.1080/14712598.2023.2276288
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1035 / 1038
页数：4
相关论文
共 50 条
  • [1] Current Trends in the Clinical Development of Antibody-Drug Conjugates in Oncology
    Dott J.
    Abila B.
    Wuerthner J.U.
    Pharmaceutical Medicine, 2018, 32 (4) : 259 - 273
  • [2] Insights on the immunogenicity of antibody-drug conjugates
    Carrasco-Triguero, Montserrat
    BIOANALYSIS, 2015, 7 (13) : 1565 - 1568
  • [3] Antibody-Drug Conjugates Challenges and Trends
    Rohrer, Thomas
    Genetic Engineering and Biotechnology News, 2024, 44 (03):
  • [4] Novel antibody-drug conjugates: current and future roles in gynecologic oncology
    Tymon-Rosario, Joan
    Zeybek, Burak
    Santin, Alessandro D.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 26 - 33
  • [5] Antibody-drug conjugates come of age in oncology
    Dumontet, Charles
    Reichert, Janice M. M.
    Senter, Peter D. D.
    Lambert, John M. M.
    Beck, Alain
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 641 - 661
  • [6] An FDA oncology analysis of antibody-drug conjugates
    Saber, Haleh
    Leighton, John K.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 71 (03) : 444 - 452
  • [7] Antibody-Drug Conjugates in Uro-Oncology
    Sigorski, Dawid
    Rozanowski, Pawel
    Izycka-Swieszewska, Ewa
    Wiktorska, Katarzyna
    TARGETED ONCOLOGY, 2022, 17 (03) : 203 - 221
  • [8] Optimizing the potential of antibody-drug conjugates in oncology
    Mosele, F.
    Montagnac, G.
    Pistilli, B.
    Andre, F.
    ANNALS OF ONCOLOGY, 2023, 34 (11) : 964 - 967
  • [9] Meeting Challenges for Analysis of Antibody-Drug Conjugates
    Xiao, Yi Qun
    Halford, Andreea
    Hayes, Roger N.
    BIOPHARM INTERNATIONAL, 2012, 25 (10) : 60 - 63
  • [10] Risk Minimization of Antibody-Drug Conjugates in Oncology: A Review
    Lievano, Fabio A.
    Scarazzini, Linda J.
    Tyczynski, Jerzy E.
    Schubert, Charles M.
    Renz, Cheryl L.
    DRUG SAFETY, 2021, 44 (07) : 733 - 742
12345